Hanon O, Vidal JS, Pisica-Donose G, Orvoen G, et al. Bleeding risk with rivaroxaban compared with vitamin K antagonists in patients
aged 80 years or older with atrial fibrillation. Heart 2020 Dec 1. pii: heartjnl-2020-317923. doi: 10.1136/heartjnl-2020-317923.
PMID: 33262185